Document is current
Any future updates will be listed below
-
Authors
Davies, Laura
Shehadeh, Rasheed
Watkins, W. John https://orcid.org/0000-0003-3262-6588
Jolles, Stephen https://orcid.org/0000-0002-7394-6804
Robertson, Neil P.
Tallantyre, Emma C. https://orcid.org/0000-0002-3760-6634
- License Information
-
More Information
Article History
Received: 11 December 2024
Revised: 28 April 2025
Accepted: 1 May 2025
First Online: 22 May 2025
Declarations
:
: In the last 5 years ET has received honorarium for consulting work from Biogen, Janssen, Merck, Novartis, and Roche. She has received travel grants to attend or speak at educational meetings from Biogen, Merck, Neuroax, Roche, and Novartis. SJ has received support for conferences, speaker, advisory boards, trials, data and safety monitoring boards, studies and projects with CSL Behring, Takeda, Octapharma, Grifols, BPL, LFB, Kedrion, Pharming, Biocryst, Capitainer, Swedish Orphan Biovitrum, Biotest, Binding Site, GSK, Sanofi, UCB Pharma and HCRW. LD, RS, WJW report no conflicts of interest.
: This human study has been approved by a UK research ethics committee and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study.
